|
|
Variable Name,Description
|
|
|
geo_accession,GEO sample accession number (GSM).
|
|
|
ID,Subject identifier within one study (unique per participant)
|
|
|
study_ID,Study or cohort identifier
|
|
|
tissue,"Sample source (e.g., whole blood, PBMC, nasal swab)."
|
|
|
platform,"Gene expression platform used (e.g., RNA-seq, microarray, scRNA-seq)."
|
|
|
pathogen,"Infectious agent studied (e.g., SARS-CoV-2, influenza)."
|
|
|
batch,Technical or experimental batch ID within one study
|
|
|
title,Sample title from GEO metadata.
|
|
|
timepoint,Exact time or day post-vaccination/infection.
|
|
|
timepoint_group,Categorical grouping of timepoints
|
|
|
infection_group,"Infection status grouping (e.g., infected vs. uninfected); represents the outcome in inoculation studies."
|
|
|
symptom_group,"Symptom severity group (e.g., symptomatic vs. asymptomatic); represents the outcome in inoculation studies."
|
|
|
symptom_group_original,Original symptom classification from source study.
|
|
|
Total_DSS,Disease Severity Score (quantitative summary of symptoms).
|
|
|
MFC,Maximum fold change (MFC)
|
|
|
responder,"Indicator of vaccine response (e.g., responder, moderate responder, or non-responder), defined based on Maximum Fold Change (MFC)."
|
|
|
responder_original,Original response classification before harmonization.
|
|
|
study_group,"Group assignment within a study (e.g., vaccine arm, control)."
|
|
|
Enrollment_year,Year when participant enrolled in the study.
|
|
|
vaccine,"Vaccine type (e.g., mRNA-1273, BNT162b2)."
|
|
|
vaccine_dose,"Vaccine dose number (e.g., 1st, 2nd, 3rd)."
|
|
|
sex,Biological sex (Male/Female).
|
|
|
age,Participant age in years.
|
|
|
age_group,"Age category (e.g., 18–30, 31–50, >50)."
|
|
|
immport_expsamp_acc,ImmPort experiment sample accession.
|
|
|
Expsample.Accession,Alternate experimental sample accession in ImmPort
|
|
|
ethnicity,"Participant ethnicity (e.g., Hispanic, non-Hispanic)."
|
|
|
race,"Race as recorded in metadata (e.g., White, Asian, Black)."
|
|
|
race_ethnicity,Combined race and ethnicity classification.
|
|
|
sham,Indicator for sham or placebo treatment.
|
|
|
BMI,Body Mass Index (kg/m²).
|
|
|
PreviousCOVID19,Prior SARS-CoV-2 infection (Yes/No).
|
|
|
symptom_group_previous_covid,Symptom group classification for previously infected individuals.
|
|
|
UnderlyingDisease,Presence of underlying or chronic medical conditions.
|
|
|
turbo_reatment,Indicator of whether the RNA sample was treated with TurboDNase (Thermo Fisher Scientific) to remove contaminating genomic DNA during RNA extraction. Marked as “Turbo Treated” if DNase treatment was applied.
|
|
|
Medications,Medications taken by participant during study.
|
|
|
side_effect,Reported vaccine side effects.
|
|
|
Duration_of_symptoms,Duration (in days) of reported symptoms.
|
|
|
days.since.covid.19.diagnosis,Days since COVID-19 diagnosis at time of sampling.
|
|
|
Vaccinated.in.prior.3.seasons,Whether vaccinated in the prior three influenza seasons (Yes/No).
|
|
|
influenza.vaccination.count..previous.10.years.,Number of influenza vaccinations received in the previous 10 years.
|
|
|
Height_cm,Height in centimeters.
|
|
|
Weight_kg,Weight in kilograms.
|
|
|
Current.smoker,Current smoking status (Yes/No).
|
|
|
Prior.smoker,Former smoking status (Yes/No).
|
|
|
Sleep.apnea,Presence of sleep apnea (Yes/No).
|
|
|
diabetes,Presence of diabetes (Yes/No).
|
|
|
seroconversion,Binary or quantitative measure of antibody seroconversion.
|
|
|
viral_shedding,Presence or level of viral shedding post-infection or vaccination. |
